Business Description
BactiQuant AS
ISIN : DK0061417730
Share Class Description:
OCSE:BACTIQ: Ordinary SharesTotal Employee Number:
12Compare
Compare
Traded in other countries / regions
BACTIQ.Denmark9JX.Germany IPO Date
2021-02-05Description
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.07 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.5 | |||||
Debt-to-EBITDA | -0.83 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.63 | |||||
Beneish M-Score | -3.07 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.2 | |||||
3-Year EBITDA Growth Rate | 15.1 | |||||
3-Year EPS without NRI Growth Rate | 10.7 | |||||
3-Year FCF Growth Rate | 25.5 | |||||
3-Year Book Growth Rate | -9.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.33 | |||||
9-Day RSI | 28.31 | |||||
14-Day RSI | 29.01 | |||||
3-1 Month Momentum % | 15.16 | |||||
6-1 Month Momentum % | -14.02 | |||||
12-1 Month Momentum % | 27.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.02 | |||||
Quick Ratio | 5.01 | |||||
Cash Ratio | 4.57 | |||||
Days Inventory | 142.19 | |||||
Days Sales Outstanding | 69.93 | |||||
Days Payable | 49.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.4 | |||||
Shareholder Yield % | -31.38 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -26.35 | |||||
Operating Margin % | -150.24 | |||||
Net Margin % | -166.3 | |||||
EBITDA Margin % | -124.98 | |||||
FCF Margin % | -126.33 | |||||
OCF Margin % | -126.33 | |||||
ROE % | -159.93 | |||||
ROA % | -67.5 | |||||
ROIC % | -122.34 | |||||
3-Year ROIIC % | -13.32 | |||||
ROC (Joel Greenblatt) % | -284.62 | |||||
ROCE % | -75.61 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 9.88 | |||||
PB Ratio | 5.41 | |||||
Price-to-Tangible-Book | 6.83 | |||||
EV-to-EBIT | -6.7 | |||||
EV-to-EBITDA | -7.99 | |||||
EV-to-Revenue | 9.98 | |||||
EV-to-FCF | -8.12 | |||||
Price-to-GF-Value | 1.04 | |||||
| Price-to-Net-Current-Asset-Value | 7.24 | |||||
| Price-to-Net-Cash | 12.95 | |||||
Earnings Yield (Greenblatt) % | -14.92 | |||||
FCF Yield % | -11.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BactiQuant AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 8.318 | ||
| EPS (TTM) (kr) | -0.46 | ||
| Beta | 1.3502 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.65 | ||
| Volatility % | 78.76 | ||
| 14-Day RSI | 29.01 | ||
| 14-Day ATR (kr) | 0.151174 | ||
| 20-Day SMA (kr) | 2.838 | ||
| 12-1 Month Momentum % | 27.86 | ||
| 52-Week Range (kr) | 2.005 - 4 | ||
| Shares Outstanding (Mil) | 37.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BactiQuant AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BactiQuant AS Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-08-27 | In 54 days | ||
| Second quarter earnings results for 2026 | 2026-08-27 | In 54 days | ||
| General meeting for 2026 | 2026-04-23 | 3.36 (+2.75%) | ||
| Annual report for 2025 | 2026-03-18 | 3.10 (+10.34%) | ||
| Second quarter earnings results for 2025 | 2025-08-27 | 2.38 (+2.37%) | ||
| General meeting for 2025 | 2025-04-23 15:00 | 2.89 (-3.51%) | ||
| Annual report for 2024 | 2025-03-20 | 3.68 (+2.22%) | ||
| Second quarter earnings results for 2024 | 2024-08-27 | 4.86 (+0.93%) |
Show
Entries
BactiQuant AS Frequently Asked Questions
What is BactiQuant AS(OCSE:BACTIQ)'s stock price today?
The current price of OCSE:BACTIQ is kr2.46. The 52 week high of OCSE:BACTIQ is kr4.00 and 52 week low is kr2.01.
When is next earnings date of BactiQuant AS(OCSE:BACTIQ)?
The next earnings date of BactiQuant AS(OCSE:BACTIQ) is 2026-08-27 Est..
Does BactiQuant AS(OCSE:BACTIQ) pay dividends? If so, how much?
BactiQuant AS(OCSE:BACTIQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BactiQuant AS
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers